{"id":49163,"date":"2025-11-27T21:16:52","date_gmt":"2025-11-27T13:16:52","guid":{"rendered":"https:\/\/flcube.com\/?p=49163"},"modified":"2025-11-27T21:16:54","modified_gmt":"2025-11-27T13:16:54","slug":"microtechs-linx-cgm-wins-india-approval-expanding-asia-diabetes-monitoring","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=49163","title":{"rendered":"MicroTech&#8217;s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring"},"content":{"rendered":"\n<p><strong>MicroTech Medical (Hangzhou) Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/2235:HKG\">HKG: 2235<\/a>) announced that its <strong>LinX Continuous Glucose Monitoring (CGM) System<\/strong> (international brand name <strong>AiDEX X<\/strong>) received marketing approval in <strong>India<\/strong> for continuous and dynamic blood glucose monitoring in adults, marking the company\u2019s first major regulatory expansion into the <strong>South Asian diabetes market<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Product<\/strong><\/td><td>LinX CGM System (AiDEX X)<\/td><\/tr><tr><td><strong>Company<\/strong><\/td><td>MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)<\/td><\/tr><tr><td><strong>Agency<\/strong><\/td><td>Indian Regulatory Authority (CDSCO)<\/td><\/tr><tr><td><strong>Approval Type<\/strong><\/td><td>Marketing authorization<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>Continuous glucose monitoring in adults with diabetes<\/td><\/tr><tr><td><strong>Geography<\/strong><\/td><td>India (world\u2019s second\u2011largest diabetes population)<\/td><\/tr><tr><td><strong>Next Step<\/strong><\/td><td>Commercial launch via distribution partners H1\u202f2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-company-amp-product-profile\">Company &amp; Product Profile<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Founded:<\/strong> 2011 \u2013 Focused on diabetes treatment and monitoring devices<\/li>\n\n\n\n<li><strong>Listed:<\/strong> Hong Kong Stock Exchange (HKEX) on <strong>19\u202fOct\u202f2021<\/strong> (2235.HK)<\/li>\n\n\n\n<li><strong>Technology:<\/strong> <strong>LinX CGM<\/strong> offers real\u2011time, dynamic glucose monitoring with 14\u2011day sensor wear<\/li>\n\n\n\n<li><strong>Competitive Edge:<\/strong> <strong>Cost\u2011effective<\/strong> alternative to multinational CGM brands; calibrated for Asian patient physiology<\/li>\n\n\n\n<li><strong>Global Strategy:<\/strong> Aims to optimize diabetes management in China and <strong>emerging markets<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-outlook\">Market Context &amp; Outlook<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>Value<\/th><\/tr><\/thead><tbody><tr><td><strong>India Diabetes Population<\/strong><\/td><td><strong>77\u202fmillion<\/strong> diagnosed (2024); 25% use CGM<\/td><\/tr><tr><td><strong>India CGM Market Size<\/strong><\/td><td>\u20b94,200\u202fcrore (~US$500\u202fmillion)<\/td><\/tr><tr><td><strong>Growth CAGR<\/strong><\/td><td>22% (2024\u20112030)<\/td><\/tr><tr><td><strong>MicroTech Market Share Target<\/strong><\/td><td>10\u201115% by 2028<\/td><\/tr><tr><td><strong>Peak Sales Forecast (India)<\/strong><\/td><td><strong>US$80\u2011120\u202fmillion<\/strong> annually by 2029<\/td><\/tr><tr><td><strong>Pricing Strategy<\/strong><\/td><td>30\u201140% discount vs. <strong>Dexcom<\/strong> and <strong>Abbott FreeStyle<\/strong> to capture price\u2011sensitive segment<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Distribution:<\/strong> Partnership negotiations with <strong>Apollo Hospitals<\/strong> and <strong>Fortis Healthcare<\/strong> underway; coverage of <strong>50\u201180<\/strong> tier\u20111\/2 hospitals by end\u20112026<\/li>\n\n\n\n<li><strong>Reimbursement Path:<\/strong> India\u2019s <strong>Ayushman Bharat<\/strong> program may include CGM for Type\u202f1 patients; private insurance coverage expanding<\/li>\n\n\n\n<li><strong>Manufacturing:<\/strong> <strong>Hangzhou facility<\/strong> can supply <strong>2\u202fmillion sensors\/year<\/strong>; dedicated India assembly line planned <strong>2027<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding LinX CGM\u2019s commercial launch, market penetration, and revenue projections in India. Actual results may differ materially due to risks including competitive responses, distribution challenges, and regulatory changes.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2025112601209_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2025112601209_c.\"><\/object><a id=\"wp-block-file--media-72fd6b6d-ea30-4680-9ac6-f5ae797e9341\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2025112601209_c.pdf\">2025112601209_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2025112601209_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-72fd6b6d-ea30-4680-9ac6-f5ae797e9341\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that its LinX Continuous Glucose Monitoring (CGM)&#8230;<\/p>\n","protected":false},"author":1,"featured_media":49166,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[39,3428,3429,15],"class_list":["post-49163","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-diabetes","tag-hkg-2235","tag-microtech-medical","tag-product-approvals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MicroTech&#039;s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that its LinX Continuous Glucose Monitoring (CGM) System (international brand name AiDEX X) received marketing approval in India for continuous and dynamic blood glucose monitoring in adults, marking the company\u2019s first major regulatory expansion into the South Asian diabetes market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=49163\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MicroTech&#039;s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring\" \/>\n<meta property=\"og:description\" content=\"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that its LinX Continuous Glucose Monitoring (CGM) System (international brand name AiDEX X) received marketing approval in India for continuous and dynamic blood glucose monitoring in adults, marking the company\u2019s first major regulatory expansion into the South Asian diabetes market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=49163\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-27T13:16:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-27T13:16:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2703-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49163#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49163\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"MicroTech&#8217;s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring\",\"datePublished\":\"2025-11-27T13:16:52+00:00\",\"dateModified\":\"2025-11-27T13:16:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49163\"},\"wordCount\":307,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49163#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2703-1.webp\",\"keywords\":[\"Diabetes\",\"HKG: 2235\",\"MicroTech Medical\",\"Product approvals\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=49163#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49163\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=49163\",\"name\":\"MicroTech's LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49163#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49163#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2703-1.webp\",\"datePublished\":\"2025-11-27T13:16:52+00:00\",\"dateModified\":\"2025-11-27T13:16:54+00:00\",\"description\":\"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that its LinX Continuous Glucose Monitoring (CGM) System (international brand name AiDEX X) received marketing approval in India for continuous and dynamic blood glucose monitoring in adults, marking the company\u2019s first major regulatory expansion into the South Asian diabetes market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49163#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=49163\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49163#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2703-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/2703-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"MicroTech's LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49163#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MicroTech&#8217;s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MicroTech's LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring - Insight, China&#039;s Pharmaceutical Industry","description":"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that its LinX Continuous Glucose Monitoring (CGM) System (international brand name AiDEX X) received marketing approval in India for continuous and dynamic blood glucose monitoring in adults, marking the company\u2019s first major regulatory expansion into the South Asian diabetes market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=49163","og_locale":"en_US","og_type":"article","og_title":"MicroTech's LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring","og_description":"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that its LinX Continuous Glucose Monitoring (CGM) System (international brand name AiDEX X) received marketing approval in India for continuous and dynamic blood glucose monitoring in adults, marking the company\u2019s first major regulatory expansion into the South Asian diabetes market.","og_url":"https:\/\/flcube.com\/?p=49163","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-27T13:16:52+00:00","article_modified_time":"2025-11-27T13:16:54+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2703-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=49163#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=49163"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"MicroTech&#8217;s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring","datePublished":"2025-11-27T13:16:52+00:00","dateModified":"2025-11-27T13:16:54+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=49163"},"wordCount":307,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=49163#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2703-1.webp","keywords":["Diabetes","HKG: 2235","MicroTech Medical","Product approvals"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=49163#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=49163","url":"https:\/\/flcube.com\/?p=49163","name":"MicroTech's LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=49163#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=49163#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2703-1.webp","datePublished":"2025-11-27T13:16:52+00:00","dateModified":"2025-11-27T13:16:54+00:00","description":"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that its LinX Continuous Glucose Monitoring (CGM) System (international brand name AiDEX X) received marketing approval in India for continuous and dynamic blood glucose monitoring in adults, marking the company\u2019s first major regulatory expansion into the South Asian diabetes market.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=49163#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=49163"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=49163#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2703-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2703-1.webp","width":1080,"height":608,"caption":"MicroTech's LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=49163#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"MicroTech&#8217;s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/2703-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=49163"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49163\/revisions"}],"predecessor-version":[{"id":49168,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49163\/revisions\/49168"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/49166"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=49163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=49163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=49163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}